Life Sciences

Bulgaria Plays Catch-Up: A Buzz Interview with Boris Lazarov of Penkov Markov & Partners

Bulgaria's outlook is improving, with its elected government working hard to catch up on crucial EU legal updates, while the country continues to attract investments in banking, energy, healthcare, and technology, according to Penkov Markov & Partners Associated Partner Boris Lazarov.

Gessel Advises Lux Med Group on Investment in Orthos

Gessel has advised Lux Med Group on investment in the Orthos hospital and clinic.

Havel & Partners Promotes Five to Partner and Ondrej Florian to Equity Partner

Ondrej Florian has become an Equity Partner at Havel & Partners, while Katerina Slavikova, Jaroslav Baier, Ondrej Curilla, Petr Oplustil, and Miroslav Vozab were appointed as Partners at the firm.

Herbst Kinsky Advises Biogena on Crowd Investment via Rockets Investments

Herbst Kinsky has advised Salzburg-based dietary supplement manufacturer Biogena on a public offering for crowd-investors via the Rockets Investments platform with a total amount of up to EUR 3 million.

Gessel Advises Bioceltix on Non-Brokered Public Offering

Gessel has advised Bioceltix on a non-brokered public offering of shares carried out under an accelerated book-building procedure and the related private placement.

Tall Order for Kosovo's Assembly: A Buzz Interview with Visar Ramaj of RPHS Law

The healthcare industry is undergoing reform and the renewable energy sector is shifting to foreign-investment-friendly auction-based strategies, while the new Civil Code and large investment projects – including healthcare digitalization and infrastructure development – are on the books in Kosovo, according to RPHS Law Partner Visar Ramaj.

Gessel Advises Genomtec on Non-Brokered Public Offering

Gessel has advised Genomtec on a non-brokered public offering carried out under an accelerated book-building procedure and the related private placement of the company’s newly issued shares.